Greenwich LifeSciences, Inc.
GLSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,807 | $3,125 | $2,750 | $4,092 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $3,807 | $3,125 | $2,750 | $4,092 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $1 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $1 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,807 | $3,125 | $2,751 | $4,094 |
| Liabilities | – | – | – | – |
| Payables | $1,109 | $1,076 | $827 | $1,178 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $513 | $0 | $305 | $382 |
| Total Curr. Liab. | $1,622 | $1,686 | $1,439 | $1,560 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,622 | $1,686 | $1,439 | $1,560 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $14 | $13 | $13 | $13 |
| Retained Earnings | -$77,589 | -$73,437 | -$69,412 | -$66,153 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $79,760 | $0 | $0 | $0 |
| Total Equity | $2,185 | $1,439 | $1,312 | $2,534 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,807 | $3,125 | $2,751 | $4,094 |
| Net Debt | -$3,807 | -$3,125 | -$2,750 | -$4,092 |